LFA
CELG

Legacy Financial Advisors’s Celgene Corp CELG Stock Holding History

Legacy Financial Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-988
Closed -$93K – 1071
2019
Q1 		$93K Buy
988
+163
+20% +$14.3K 0.03% 176
2018
Q4 		$53K Buy
825
+315
+62% +$23.3K 0.02% 236
2018
Q3 		$45K Buy
510
+60
+13% +$5.3K 0.02% 268
2018
Q2 		$39K Hold
450
– – 0.01% 280
2018
Q1 		$40K Sell
450
-27
-6% -$2.59K 0.02% 272
2017
Q4 		$49K Buy
+477
New +$53.8K 0.02% 243

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Legacy Financial Advisors's CELG Position: Q2 2019 in Review

Legacy Financial Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 988 shares — an estimated $93K sold.

Legacy Financial Advisors first reported a position in CELG in Q4 2017 and held it in 6 quarters. The position peaked at $93K in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Legacy Financial Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Legacy Financial Advisors sold 988 Celgene Corp shares in Q2 2019, an estimated $93K.
  • Legacy Financial Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 6 quarters.
  • Legacy Financial Advisors's Celgene Corp position peaked at $93K in Q1 2019.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Legacy Financial Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.